Applied Molecular Transport Total Non Current Liabilities 2011-2026 | AMTI

Annual Total Non Current Liabilities Applied Molecular Transport

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	106 M	64.2 M	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
106 M	64.2 M	85.2 M

Total Non Current Liabilities of other stocks in the Biotechnology industry

Issuer	Total Non Current Liabilities	Price	% 24h	Market Cap	Country
AbCellera Biologics ABCL	326 M	$ 3.65	-1.75 %	$ 1.09 B	Canada
ADMA Biologics ADMA	99.5 M	$ 16.5	0.73 %	$ 3.93 B	USA
MorphoSys AG MOR	40.2 M	-	2.43 %	$ 254 M	Germany
Apellis Pharmaceuticals APLS	289 M	$ 19.78	-1.89 %	$ 2.5 B	USA
Aptorum Group Limited APM	2.21 M	$ 0.82	4.04 %	$ 4.47 M	China
Graybug Vision GRAY	11 K	-	-11.23 %	$ 9.65 M	USA
Axsome Therapeutics AXSM	48.9 M	$ 164.62	0.34 %	$ 8.19 B	USA
I-Mab IMAB	131 M	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	4.83 B	-	-	$ 40.3 B	USA
Acer Therapeutics ACER	244 K	-	2.71 %	$ 14 M	USA
Biophytis SA BPTS	2.02 M	-	-13.47 %	$ 169 M	France
Ampio Pharmaceuticals AMPE	3.53 M	-	-11.43 %	$ 502 K	USA
BioLineRx Ltd. BLRX	8.22 M	$ 2.93	4.27 %	$ 908 M	Israel
Athersys ATHX	5.4 M	-	3.77 %	$ 22.4 M	USA
EyeGate Pharmaceuticals, Inc. EYEG	6.39 M	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	110 K	-	-18.52 %	$ 27.3 M	Britain
AVEO Pharmaceuticals AVEO	14.7 M	-	-	$ 521 M	USA
BioMarin Pharmaceutical BMRN	635 M	$ 59.93	2.39 %	$ 11.5 B	USA
Brainstorm Cell Therapeutics BCLI	618 K	-	-2.5 %	$ 5.88 M	USA
BioDelivery Sciences International BDSI	78.7 M	-	-4.8 %	$ 255 M	USA
Cabaletta Bio CABA	43.9 M	$ 3.37	3.66 %	$ 3.94 M	USA
BridgeBio Pharma BBIO	97.6 M	$ 65.44	1.41 %	$ 12.5 B	USA
Adverum Biotechnologies ADVM	27.3 M	-	-	$ 86.2 M	USA
CymaBay Therapeutics CBAY	1.26 M	-	-	$ 3.45 B	USA
Институт стволовых клеток человека ISKJ	541 M	-	-	-	Russia
Avid Bioservices CDMO	21.2 M	-	-	$ 789 M	USA
ARCA biopharma ABIO	409 K	-	1052.0 %	$ 415 M	USA
Codexis CDXS	28.2 M	$ 1.04	6.29 %	$ 76.3 M	USA
Checkpoint Therapeutics CKPT	2.47 M	-	-	$ 169 M	USA
Caladrius Biosciences CLBS	254 K	-	-16.75 %	$ 25.8 M	USA
Alpine Immune Sciences ALPN	15.9 M	-	-	$ 2.17 B	USA
Clovis Oncology CLVS	579 M	-	-7.23 %	$ 13 M	USA
Acorda Therapeutics ACOR	257 M	-	-24.86 %	$ 820 K	USA
Coherus BioSciences CHRS	189 M	$ 1.75	5.76 %	$ 165 M	USA
Acasti Pharma ACST	12.2 M	-	4.01 %	$ 150 M	Canada
CTI BioPharma Corp. CTIC	1.17 M	-	-	$ 1.2 B	USA
CohBar CWBR	349 K	-	-15.44 %	$ 2.2 M	USA
Cyclacel Pharmaceuticals CYCC	1.06 M	-	-5.98 %	$ 34.1 M	USA
Cyclacel Pharmaceuticals CYCCP	1.06 M	-	-4.36 %	$ 27 M	USA
Deciphera Pharmaceuticals DCPH	15.9 M	-	-	$ 2.18 B	USA
CureVac N.V. CVAC	112 M	-	-	$ 867 M	Germany
Capricor Therapeutics CAPR	4.86 M	$ 26.27	1.66 %	$ 703 M	USA
Aeterna Zentaris AEZS	19.1 M	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	1.53 M	-	-10.17 %	$ 12.2 K	USA
Certara CERT	482 M	$ 7.3	0.83 %	$ 1.17 B	USA
Aeglea BioTherapeutics AGLE	4.74 M	-	-	$ 1.01 B	USA
Citius Pharmaceuticals CTXR	6.01 M	$ 0.82	10.93 %	$ 5.52 M	USA
Entasis Therapeutics Holdings ETTX	704 K	-	-	$ 105 M	USA